Princeps Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 211.29%
(FY 2022)
- Profit 145.46%
(FY 2022)
- Ebitda 139.05%
(FY 2022)
- Net Worth 47.30%
(FY 2022)
- Total Assets -67.85%
(FY 2022)
About Princeps Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pascal Postel, Lalsa Yadav, Vitalapuram Subramanian, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230TN2000PTC073993
- Company No.
073993
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2000
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- LocationChennai, Tamil Nadu
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Princeps Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pascal Postel  | Director | 04-Jan-2021 | Current |
| Lalsa Yadav | Director | 01-Sep-2007 | Current |
| Vitalapuram Subramanian | Director | 29-Oct-2013 | Current |
| Dinesh Jain | Director | 27-Jan-2018 | Current |
Financial Performance of Princeps Pharmaceuticals.
Princeps Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 211.29% increase. The company also saw a substantial improvement in profitability, with a 145.46% increase in profit. The company's net worth Soared by an impressive increase of 47.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Princeps Pharmaceuticals?
In 2022, Princeps Pharmaceuticals had a promoter holding of 18.00% and a public holding of 82.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Franco Indian Medicare Pvt LtdActive 41 years 6 monthsPascal Postel, Lalsa Yadav and 1 more are mutual person
- Franco Indian Therapeutics Pvt. Ltd.Active 38 years 7 months
Pascal Postel, Lalsa Yadav and 1 more are mutual person
- Franco-Indian Pharmaceuticals Private LimitedActive 65 years 7 months
Pascal Postel and Lalsa Yadav are mutual person
- Wardex Pharmaceuticals Private LimitedActive 78 years 5 days
Pascal Postel and Vitalapuram Subramanian are mutual person
- Franco Indian Research Private LimitedActive 51 years 9 months
Pascal Postel, Lalsa Yadav and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Princeps Pharmaceuticals?
Princeps Pharmaceuticals has a workforce of 1 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Princeps Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Princeps Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
